CAS 192374-14-4
:Radafaxin
- 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-
- (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol
- (2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol
- 2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S-cis)-
- Radafaxine
2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-
CAS:Formel:C13H19Cl2NO2Farbe und Form:SolidMolekulargewicht:292.2015(S,S)-Hydroxy Bupropion
CAS:Formel:C13H18ClNO2Farbe und Form:White To Off-White SolidMolekulargewicht:255.74(S,S)-Hydroxy Bupropion
CAS:Applications (S,S) Enantiomer metabolite of Bupropion (B689625), an antidepressant.
References Hsyu, P-H., et al.: J. Clin. Pharm., 37, 737 (1997), Rotzinger, S., et al.: Cellular & Mol. Neurobiology, 19, 4, 427 (1999); US 6342496Formel:C13H18ClNO2·ClHFarbe und Form:NeatMolekulargewicht:292.2(S,S)-Hydroxy bupropion
CAS:(S,S)-Hydroxy bupropion is a drug that is used to treat some forms of depression in humans. It is a dopaminergic agent that acts on the dopamine receptor and has been shown to be effective for the treatment of some metabolic disorders in humans. The low potency of this drug may be due to its metabolism by CYP2B6, which prevents it from being active when taken orally. This drug also has been shown to have antagonist effects against the cannabinoid receptor (CB1) and may have therapeutic potential for treating obesity and nicotine addiction.
Formel:C13H18ClNO2Reinheit:Min. 95%Molekulargewicht:255.74 g/mol




